Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: A prospective study for 18 months

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 4 I, 1998, Pages 445-450

  Wang, Wei Qing ^a   Ip, Mary Sau Man ^a   Tsang, Kenneth Wau Tak ^a   Lam, Karen Siu Ling ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Asthma; Bone loss; Bone mineral density; Corticosteroid; Etidronate

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; ETIDRONIC ACID; HYDROXYPROLINE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; STEROID;

ARTICLE; ASTHMA; BONE DENSITY; BONE METABOLISM; BONE MINERAL; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; HYDROXYPROLINE URINE LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEROID THERAPY;

EID: 0031958892     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70351-3     Document Type: Article

References (25)

1. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993;148:S1-26.
2. Ernst P, Spitzer WO, Suissa S. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992;268:3462-4.
3. Prahl P. Adrenocorticol suppression following treatment with beclomethasone and budesonide. Clin Exp Allergy 1991;21:145-6.
4. Puolijoki H, Liippo K, Herrala J, Salmi J, Tala E. Inhaled beclomethasone decreases serum osteocalcin in postmenopausal asthmatic women. Bone 1992;13:285-8.
5. Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991;88:572-80.
6. Sorva R, Turpeinen M, Juntunen-Backman K, Karonen SL, Sorva A. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol 1992;90:808-15.
7. Ip M, Lam KSL, Yam L, Kung AWC, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 1994;105:1722-7.
8. Reid IR, Ibbertson HK. Calcium supplements in the prevention of steroid induced osteoporosis. Am J Clin Nutr 1986;44:287-90.
9. Schwartz E, Panariello VA, Saeli J. Radioactive calcium kinetics during high calcium intake in osteoporosis. J Clin Invest 1965;44:1547-60.
10. Storm T, Thamsbory G, Steiniche T, Genant, Sorensen OL. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990;322:1265-71.
11. Mulder H, Struys A. Intermittent cyclical etidronate in the prevention of corticosteoroid-induced bone loss. Br J Rheumatol 1994;33:348-50.
12. Pun KK, Chan LWL, Chung V, Wong FHW. Calcium and other dietary constituents in Hong Kong Chinese in relation to age and osteoporosis. J Appl Nutrition 1990;42:12-7.
13. Holbrook TL, Barrett-Connor E. The association of lifetime weight and weight control patients with bone mineral density in an adult community. Bone Miner 1993;20:141-9.
14. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995;96:571-9.
15. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.
16. Pouw EM, Prummel MF, Oosting H, Carel MR, Endert E. Beclomethasone inhalation decreases serum osteocalcin concentration. Br Med J 1991;302:627-8.
17. Cumming RG. Calcium intake and bone mass: a quantitative review of the evidence. Calcif Tissue Int 1990;47:194-201.
18. Kanders B, Dempster DW, Lindsay R. Interaction of calcium nutrition and physical activity on bone mass in young women. J Bone Miner Res 1988;3:145-9.
19. Heaney RP. Calcium bone health, and osteoporosis. J Bone Miner Res 1986;4:255-301.
20. Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, et al. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 1993;95:557-67.
21. Liberman UA, Weiss S, Broil J, Minne HW, Quan H, Bell NH, et al. Effects of alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437-43.
22. Dull TA, Henneman PH. Urinary hydroxyproline as an index of collagen turnover in bone. N Engl J Med 1963;268:132-5.
23. Morrison D, Ali NJ, Routledge PA, Capewell S. Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease. Thorax 1992;47:418-20.
24. Ali NJ, Capewell S, Ward MJ. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 1991;46:160-4.
25. Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HSP. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 1991;72:382-6.